Table 4.
HLA-KIR combination | Frequency in cases | Frequency in controls | Odds ratio | 95% CI | p value 1 |
---|---|---|---|---|---|
HLA-C1 and KIR2DL2/3 | 41 (82%) | 75 (75%) | 1.518 | 0.768-3.003 | 0.4482 |
HLA-C2 and KIR2DL1 | 33 (66%) | 69 (69%) | 0.872 | 0.482-1.577 | 0.8527 |
HLA-Bw4 and KIR3DL1 | 40 (80%) | 69 (69%) | 1.797 | 0.940-3.435 | 0.2184 |
HLA-C1 and KIR2DS2 | 28 (56%) | 43 (43%) | 1.687 | 0.964-2.951 | 0.1836 |
HLA-C2 and KIR2DS1 | 14 (28%) | 36 (36%) | 0.691 | 0.380-1.257 | 0.4260 |
HLA-Bw4 and KIR3DS1 | 18 (36%) | 35 (35%) | 1.044 | 0.585-1.864 | 0.9039 |
Chi-square with Yate's correction.